http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9510270-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ebb6a553affdc364c91cffe3baf12564 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate | 1994-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9358b1261437c3b4cff92536d5200a94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ca36d47a11e747fc370dd1e4126f914 |
| publicationDate | 1995-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9510270-A1 |
| titleOfInvention | Method for treating urinary incontinence using optically pure s-terodiline |
| abstract | Methods and compositions are disclosed utilizing the optically pure S-isomers of terodiline or of the hydroxylated derivatives of terodiline. These compounds are potent drugs for the treatment of urinary incontinence, obstructive pulmonary disease and such other conditions as are related to the compounds' activity as anticholinergic agents. Furthermore, the optically pure S-isomers of terodiline or of the hydroxylated derivatives of terodiline are useful for the treatment of angina and such other conditions as may be related to the compounds' activity as calcium antagonists. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7439397-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9800011-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6890920-B2 |
| priorityDate | 1993-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 111.